ACADIA PHARMACEUTICALS INC's ticker is and the CUSIP is 004225908. A total of 6 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,137,380 | -11.3% | 294,500 | +2.0% | 0.02% | -4.5% |
| Q2 2023 | $6,916,760 | +34.8% | 288,800 | +5.9% | 0.02% | +15.8% |
| Q1 2023 | $5,132,214 | +13.7% | 272,700 | -3.8% | 0.02% | +90.0% |
| Q4 2022 | $4,513,320 | +3.9% | 283,500 | +6.8% | 0.01% | +11.1% |
| Q3 2022 | $4,344,000 | +354.9% | 265,500 | +291.6% | 0.01% | +800.0% |
| Q2 2022 | $955,000 | -67.5% | 67,800 | -44.1% | 0.00% | -66.7% |
| Q1 2022 | $2,938,000 | -68.1% | 121,300 | -69.3% | 0.00% | -57.1% |
| Q4 2021 | $9,212,000 | +828.6% | 394,700 | +561.1% | 0.01% | +600.0% |
| Q3 2021 | $992,000 | -63.9% | 59,700 | -47.0% | 0.00% | -66.7% |
| Q2 2021 | $2,746,000 | +223.4% | 112,600 | +242.2% | 0.00% | +200.0% |
| Q1 2021 | $849,000 | -91.7% | 32,900 | -82.8% | 0.00% | -94.4% |
| Q4 2020 | $10,200,000 | +38.4% | 190,800 | +6.8% | 0.02% | -21.7% |
| Q3 2020 | $7,371,000 | -20.6% | 178,700 | -6.7% | 0.02% | -46.5% |
| Q2 2020 | $9,287,000 | +22.8% | 191,600 | +7.0% | 0.04% | -29.5% |
| Q1 2020 | $7,563,000 | -24.0% | 179,000 | -23.0% | 0.06% | -10.3% |
| Q4 2019 | $9,946,000 | +19.5% | 232,500 | +0.5% | 0.07% | +1.5% |
| Q3 2019 | $8,324,000 | +131.4% | 231,300 | +71.8% | 0.07% | +103.0% |
| Q2 2019 | $3,598,000 | -52.7% | 134,600 | -52.4% | 0.03% | -61.2% |
| Q1 2019 | $7,599,000 | +102.8% | 283,000 | +22.1% | 0.08% | +165.6% |
| Q4 2018 | $3,747,000 | -22.9% | 231,700 | -1.1% | 0.03% | -15.8% |
| Q3 2018 | $4,862,000 | +59.5% | 234,200 | +17.3% | 0.04% | +46.2% |
| Q2 2018 | $3,048,000 | +7.9% | 199,600 | +58.8% | 0.03% | -7.1% |
| Q1 2018 | $2,824,000 | -56.5% | 125,700 | -41.7% | 0.03% | -39.1% |
| Q4 2017 | $6,489,000 | -0.8% | 215,500 | +24.1% | 0.05% | -22.0% |
| Q3 2017 | $6,543,000 | -15.1% | 173,700 | -37.2% | 0.06% | -26.2% |
| Q2 2017 | $7,709,000 | -26.1% | 276,400 | -8.9% | 0.08% | -33.9% |
| Q1 2017 | $10,427,000 | +17.5% | 303,300 | -1.5% | 0.12% | +40.7% |
| Q4 2016 | $8,877,000 | -26.7% | 307,800 | -53.9% | 0.09% | -71.2% |
| Q2 2013 | $12,113,000 | – | 667,400 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 200,000 | $2,818,000 | 0.16% |
| SIMPLEX TRADING, LLC | 124,300 | $1,751,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 67,800 | $955,000 | 0.00% |
| JANE STREET GROUP, LLC | 102,600 | $1,446,000 | 0.00% |
| JPMORGAN CHASE & CO | 102,700 | $1,447,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |